CARUCCI, SARA
 Distribuzione geografica
Continente #
EU - Europa 36.454
NA - Nord America 3.125
AS - Asia 2.328
SA - Sud America 429
AF - Africa 135
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 42.485
Nazione #
IT - Italia 35.059
US - Stati Uniti d'America 3.000
SG - Singapore 1.004
CN - Cina 619
BR - Brasile 343
SE - Svezia 284
VN - Vietnam 269
FR - Francia 255
DE - Germania 171
FI - Finlandia 124
GB - Regno Unito 113
HK - Hong Kong 94
NL - Olanda 88
UA - Ucraina 85
ZA - Sudafrica 85
IN - India 82
BE - Belgio 59
CA - Canada 58
CH - Svizzera 41
MX - Messico 39
BD - Bangladesh 35
KR - Corea 30
RU - Federazione Russa 30
AR - Argentina 25
ID - Indonesia 25
TR - Turchia 23
AT - Austria 21
RO - Romania 21
CO - Colombia 19
IQ - Iraq 19
ES - Italia 17
MA - Marocco 17
PL - Polonia 17
JP - Giappone 15
SA - Arabia Saudita 14
AU - Australia 13
AE - Emirati Arabi Uniti 12
EC - Ecuador 12
MY - Malesia 12
PK - Pakistan 11
UZ - Uzbekistan 10
VE - Venezuela 10
IE - Irlanda 9
DK - Danimarca 8
GR - Grecia 7
HN - Honduras 7
IL - Israele 7
KE - Kenya 7
NO - Norvegia 7
CL - Cile 6
CZ - Repubblica Ceca 6
LT - Lituania 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
EG - Egitto 5
LB - Libano 5
PY - Paraguay 5
TN - Tunisia 5
BO - Bolivia 4
ET - Etiopia 4
HU - Ungheria 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
PH - Filippine 4
PS - Palestinian Territory 4
PT - Portogallo 4
AL - Albania 3
BG - Bulgaria 3
LA - Repubblica Popolare Democratica del Laos 3
NP - Nepal 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AD - Andorra 2
BY - Bielorussia 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
LV - Lettonia 2
LY - Libia 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
UY - Uruguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
KH - Cambogia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
Totale 42.479
Città #
Cagliari 31.519
Uta 1.774
Singapore 578
Ashburn 361
San Jose 249
Rome 204
Nyköping 159
Boardman 155
Dallas 138
Milan 122
Council Bluffs 111
Fairfield 109
Chandler 108
Beijing 99
Woodbridge 98
Houston 90
Los Angeles 87
Helsinki 86
Hong Kong 82
Ho Chi Minh City 81
New York 67
Hefei 66
Santa Clara 66
Johannesburg 61
The Dalles 56
Hanoi 55
Genk 50
Ann Arbor 47
Lauterbourg 45
Dearborn 44
Cambridge 43
Charleston 42
Jacksonville 42
Wilmington 42
Bari 41
Shanghai 41
Palermo 40
Frankfurt am Main 39
Turin 36
Dong Ket 34
Seattle 33
São Paulo 33
Florence 31
Naples 30
Orem 28
Redondo Beach 28
Bologna 27
Boston 27
Chicago 27
Seoul 25
Catania 24
Nanjing 24
Amsterdam 23
Munich 21
Nuremberg 21
Washington 21
Messina 17
Padova 17
Bucharest 16
Silver Spring 16
Brescia 15
Buffalo 15
Castellammare di Stabia 15
Mexico City 15
Ancona 14
Lappeenranta 14
San Diego 14
San Francisco 14
Taranto 14
Brooklyn 13
Rotterdam 13
Rustenburg 13
Atlanta 12
Da Nang 12
Guangzhou 12
London 12
Montreal 12
Parma 12
Phoenix 12
Stockholm 12
Tokyo 12
Chennai 11
Haiphong 11
Urbino 11
Utrecht 11
Zurich 11
Calgary 10
Mumbai 10
Perugia 10
Salvador 10
Tianjin 10
Toronto 10
Warsaw 10
Casablanca 9
Changsha 9
Denver 9
Dhaka 9
Jakarta 9
Ottawa 9
Pescara 9
Totale 38.121
Nome #
Effetti del Metilfenidato sulla crescita in bambini e adolescenti ADHD. Revisione sistematica e monitoraggio prospettico a lungo termine dei parametri auxologici: analisi preliminari dei risultati dello studio europeo di farmacovigilanza ADDUCE 2.081
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.880
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.638
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.598
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.564
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.515
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.363
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.263
null 1.154
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 1.143
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 1.040
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 1.023
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 929
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 854
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 800
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 795
null 754
null 750
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 736
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 717
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 714
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 709
null 689
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 678
null 675
Disturbo Bipolare in età evolutiva: caratteristiche cliniche ed efficacia della terapia farmacologica 670
null 658
Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies 655
Eziologia 616
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 599
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 573
Association of Risk of Suicide Attempts With Methylphenidate Treatment 570
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 564
null 549
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 544
Management and treatment of attention-deficit/hyperactivity disorder 534
Methylphenidate effects on social functioning in children with ADHD 527
Plasma poly-unsatured fatty acids profile in children with inattentive ADHD - preliminary results of an efficacy Italian study with omega 3/6 494
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. 455
Tolerability and safety of risperidone in childhood: may specific clinical variables predict extrapyramidal averse events? 448
Face and emotion recognition in children with ADHD and autism spectrum disorders: effects of methylphenidate 440
EffEtti sulla crescita della terapia a lungo termine con metilfenidato in bambini e adolescenti con disturbo da deficit di attenzione e iperattività (ADHD) 433
Contemporary diagnosis and treatment of conduct disorder in youth 331
Phenomenology and 24 month treatment outcome of pediatric bipolar disorder 323
Long term therapy with methylphenidate induces modest effects on growth in ADHD children 311
Tolerability, safety and efficacy of long term (at least 6 months) quetiapine and aripiprazole in children and adolescents 292
Predictive factors for persistent use and compliance of immediate-release methylphenidate: A 36-month naturalistic study 284
Neurofeedback for Attention-Deficit/Hyperactivity Disorder 278
Neuropsychiatric diseases of the basal ganglia: obsessive compulsive disorder, ADHD and Tourette Syndrome Neurobiology 276
Growth on stimulant medication: effects in children with ADHD 272
Neurobiologia della Depressione in Età Evolutiva 269
Emotion recognition and social functioning in children with ADHD or autism spectrum disorders 258
The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project 193
Pandemic-related emergency psychiatric presentations for self-harm of children and adolescents in 10 countries (PREP-kids): a retrospective international cohort study 174
ABA: l’analisi comportamentale applicata 156
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 154
Medication adherence and persistence in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and qualitative update 150
Psicoterapia a indirizzo cognitivo-comportamentale 143
Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder 142
Psychopharmacology in children and adolescents: unmet needs and opportunities 132
An Evolutionary Preamble Towards a Multilevel Framework to Understand Adolescent Mental Health: An International Delphi Study 132
Methylphenidate and ADHD|Metilfenidato e ADHD 128
Lockdown stringency and paediatric self-harm presentations during COVID-19 pandemic: retrospective cohort study 126
Methylphenidate and Sleep Difficulties in Children and Adolescents With ADHD: Results From the 2-Year Naturalistic Pharmacovigilance ADDUCE Study 125
Computerized cognitive training in attention-deficit/hyperactivity disorder (ADHD): a meta-analysis of randomized controlled trials with blinded and objective outcomes 125
Professor Alessandro Zuddas’ Impact and Legacy: The Influential Networking and Human Connection Skills of a Passionate Scientist, Clinical Academic, and Pioneer in Child and Adolescent Psychopharmacology 124
REM sleep atonia in patients with pediatric acute-onset neuropsychiatric syndrome (PANS): implications for pathophysiology 121
COVID-19 Pandemic School Disruptions and Acute Mental Health in Children and Adolescents 121
Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic 121
Neurodevelopmental Disorders and Suicide: A Narrative Review 111
Emotional dysregulation, executive functions and callous-unemotional traits in children and adolescents with Oppositional Defiant Disorder/Conduct Disorder and Autism Spectrum Disorder: a direct comparison 109
Neuropsichiatria infantile 103
Social and executive functioning in individuals with autism spectrum disorder without intellectual disability: The case–control study protocol of the CNeSA study 102
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents 97
Self-Harm in Children and Adolescents Who Presented at Emergency Units During the COVID-19 Pandemic: An International Retrospective Cohort Study 94
An International Clinical Study of Ability and Disability in Autism Spectrum Disorder Using the WHO-ICF Framework 88
Editorial: Two Centimeters More or Less. How Much Does It Matter to an Adolescent or a Young Adult With Attention-Deficit/Hyperactivity Disorder? 69
Il disturbo oppositivo provocatorio 67
Research advances and future directions in female ADHD: the lifelong interplay of hormonal fluctuations with mood, cognition, and disease 57
RISPERIDONE 54
Posttraumatic disorder, eye movement desensitization and reprocessing (EMDR) 54
Suicidal risk and psychopathological profiles in adolescents with neurodevelopmental disorders: an Italian multicentric study 52
Totale 42.709
Categoria #
all - tutte 62.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021636 0 0 0 0 0 0 0 0 0 145 111 380
2021/20222.372 155 110 68 274 228 144 98 153 267 294 311 270
2022/20235.496 277 539 541 404 402 496 278 659 406 370 726 398
2023/20246.417 327 259 242 377 716 969 991 430 345 479 674 608
2024/202512.299 2.055 2.880 1.780 1.527 809 792 1.151 103 213 172 463 354
2025/20265.867 489 311 530 519 576 482 953 686 499 822 0 0
Totale 42.709